Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients

Intensive Care Medicine

Volumn 34, Issue 10, 2008, Pages 1843-1850

  Iapichino, Gaetano ^a   Albicini, Maura ^b   Umbrello, Michele ^a   Sacconi, Francesca ^a   Fermo, Isabella ^d   Pavlovich, Radmila ^a   Paroni, Rita ^a   Bellani, Giacomo ^c   Mistraletti, Giovanni ^a   Cugno, Massimo ^a   Pesenti, Antonio ^c   Gattinoni, Luciano ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

ADMA; Endocrine; Glycemic control; Insulin therapy; Sepsis

Indexed keywords

ARGININE; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFLAMMATION; INSULIN TREATMENT; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; NEUROLOGICAL COMPLICATION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPTIC SHOCK;

AGED; ARGININE; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; SEPSIS; TREATMENT OUTCOME;

EID: 52949112633     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-008-1158-9     Document Type: Article

References (34)

1. M Kimoto H Tsuji T Ogawa K Sasaoka 1993 Detection of NG, NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody Arch Biochem Biophys 300 657 662
2. M Kimoto GS Whitley H Tsuji T Ogawa 1995 Detection of NG, NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody J Biochem 117 237 238
3. JT Kielstein RH Boger SM Bode-Böger JC Frolich H Haller E Ritz D Fliser 2002 Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease J Am Soc Nephrol 13 170 176
4. B Marescau G Nagels I Possemiers ME De Broe I Becaus JM Billiouw W Lornoy PP De Deyn 1997 Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency Metabolism 46 1024 1031
5. EI Closs FZ Basha A Habermeier U Forstermann 1997 Interference of l-arginine analogues with l-arginine transport mediated by the y+ carrier hCAT-2B Nitric Oxide 1 65 73
6. SM Bode-Böger F Scalera JT Kielstein J Martens-Lobenhoffer G Breithardt M Fobker H Reinecke 2006 Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease J Am Soc Nephrol 17 1128 1134
7. P Vallance A Leone A Calver J Collier S Moncada 1992 Endogenous dimethylarginine as an inibitor of nitric oxide synthesis J Cardiovasc Pharmacol 20 S60 S62
8. A Ito PS Tsao S Adimoolam M Kimoto T Ogawa JP Cooke 1999 Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase Circulation 99 3092 3095
9. MP Siroen T Teerlink RJ Nijveldt HA Prins MC Richir PA van Leeuwen 2006 The clinical significance of asymmetric dimethylarginines Annu Rev Nutr 26 203 228
10. K Sydow T Munzel 2003 ADMA and oxidative stress Atheroscler Suppl 4 41 51
11. MC Stühlinger RK Oka EE Graf I Schmölzer BM Upson O Kapoor A Szuba MR Malinow TC Wascher O Pachinger JP Cooke 2003 Endothelial dysfunction induced by hyperhomocysteinemia: role of asymmetric dimethylarginine Circulation 108 933 938
12. R Schnabel S Blankenberg E Lubos KJ Lackner HJ Rupprecht C Espinola-Klein N Jachmann F Post D Peetz C Bickel F Cambien L Tiret T Münzel 2005 Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study Circ Res 97 e53 e59
13. JT Kielstein SM Bode-Böger G Hesse J Martens-Lobenhoffer A Takacs D Fliser MM Hoeper 2005 Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension Arterioscler Thromb Vasc Biol 25 1414 1418
14. RJ Nijveldt T Teerlink B Van Der Hoven MP Siroen DJ Kuik JA Rauwerda PA van Leeuwen 2003 Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality Clin Nutr 22 23 30
15. MP Siroen PAM Van Leeuven RJ Nijveldt T Teerlink PJ Wouters G Van den Berghe 2005 Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality? Crit Care Med 33 504 510
16. MJ O'Dwyer F Dempsey V Crowley DP Kelleher R McManus T Ryan 2006 Septic shock is correlated with asymmetrical dimethylarginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study Crit Care 10 R139
17. R Maas L Dentz E Schwedhelm W Thoms O Kuss N Hitmeyer M Hdden T Koss T Standl RH Boger 2007 Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery Crit Care Med 35 1876 1881
18. C Zoccali SM Bode-Böger F Mallamaci F Benedetto G Tripepi L Malatino A Cataliotti I Bellanuova I Fermo J Frölich RH Böger 2001 Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study Lancet 358 2113 2117
19. VP Valkonen H Paiva JT Salonen TA Lakka T Lehtimaki J Laakso R Laaksonen 2001 Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine Lancet 358 2127 2128
20. TM Lu YA Ding SJ Lin WS Lee HC Tai 2003 Plasma levels of asymmetric dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention Eur Heart J 24 1912 1919
21. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee 1992 Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med 20 864 874
22. G Van den Berghe P Wouters F Weekers C Verwaest F Bruyninckx M Schetz D Vlasselaers P Ferdinande P Lauwers R Bouillon 2001 Intensive insulin therapy in the critically ill patients N Engl J Med 345 1359 1367
23. JR Le Gall S Lemeshow F Saulnier 1993 A new Simplified Acute Physiology Score (Simplified Acute Physiology Score II) based on a European/North American multicenter study JAMA 270 2957 2963
24. JL Vincent R Moreno J Takala S Willatts A De Mendonca H Bruining CK Reinhart PM Suter LG Thijs 1996 The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure Intensive Care Med 22 707 710
25. R Paroni I Fermo P Fiorina G Cighetti 2005 Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects Amino Acids 28 389 394
26. G Iapichino D Radrizzani M Solca G Bonetti L Leoni A Ferro 1985 Influence of total parenteral nutrition on protein metabolism following acute injury: assessment by urinary 3-methylhistidine excretion and nitrogen balance J Parentr Enteral Nutr 9 42 46
27. GE Mann DL Yudilevich L Sobrevia 2003 Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells Physiol Rev 83 183 252
28. L Sobrevia A Nadal DL Yudilevich GE Mann 1996 Activation of l-arginine transport (system y+) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells J Physiol 490 775 781
29. KY Lin A Ito T Asagami PS Tsao S Adimoolam M Kimoto H Tsuji GM Reaven JP Cooke 2002 Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase Circulation 106 987 992
30. RJ Nijveldt T Teerlink MP Siroen AA van Lambalgen JA Rauwerda PA van Leeuwen 2003 The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA) Clin Nutr 22 17 22
31. J Liu M Hatzoglou 1998 Control of expression of the gene for the arginine transporter Cat-1 in rat liver cells by glucocorticoids and insulin Amino Acids 15 321 337
32. D Radrizzani G Iapichino 1998 Nutrition and lung function in the critically ill patient Clin Nutr 17 7 10
33. FM Brunkhorst C Engel F Bloos A Meier-Hellmann M Ragaller N Weiler O Moerer M Gruendling M Oppert S Grond D Olthoff U Jaschinski S John R Rossaint T Welte M Schaefer P Kern E Kuhnt M Kiehntopf C Hartog C Natansori M Loeffler K Reinhart German Competence Network Sepsis (SepNet) 2008 Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 125 139
34. P Devos JC Preiser C Melot 2007 Impact of tight glucose control by Intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucocontrol study Intensive Care Med 33 Suppl 2 S189